Buckle up, CG Oncology (NASDAQ: CGON) investors, because things are about to get bumpy...in the best way possible! Today, Wall...
Morgan Stanley
Wall Street heavyweight Morgan Stanley weighs in on CG Oncology (CGON) with an “Overweight” rating. Discover what this means for the stock’s future.
